Funding · Healthcare & Life Sciences

Redcliffe Labs raises $80 million for expansion

By Startup Enthusiast · 13 August 2023

What they do

Redcliffe Labs is a diagnostics company with self-owned labs and home sample collection

It raised $80 million to expand to 250 labs and 10,000 collection centres by 2025

The company aims to go public in 2025-26 and expects to break even by end of 2023

Redcliffe Labs raised $80 million for expansion.
It plans to add 250 labs and 10,000 collection centres by 2025.
Long-term target is 700 labs and 25,000 collection centres by 2027-28.
The company aims to go public in 2025-26.
Expansion focus is on Tier II, III, IV regions in UP, MP, Rajasthan, Bihar, Jharkhand, Chhattisgarh.
It is also strengthening presence in Maharashtra and Gujarat.
Redcliffe Labs is simplifying reports with AI technology and looking at specialised testing packages.
It expects to break even by end of 2023.

Redcliffe Labs is a diagnostics service provider with self-owned certified labs, home sample collection, smart reports, AI assistance, and diet plans.
It offers health checkup packages for various conditions: fever, heart, vitamin, diabetes, thyroid, hormones, lifestyle, cancer, pregnancy, allergy, arthritis, STD, anemia, antenatal.
It has sub-brands: Femcliffe (she-centric diagnostic platform), GeneCliffe (DNA insights), and HealthEx (curated tests by genetic experts).
It guarantees 100% report accuracy or money-back.
Website claims: 1 Crore+ lives touched, 80+ self-owned certified labs, 2,000+ collection centres, 1500+ trained phlebotomists.

Add 250 labs and 10,000 collection centres by 2025.
Reach 700 labs and 25,000 collection centres by 2027-28.
Go public in 2025-26.
Expand in Tier II, III, IV regions and strengthen presence in Maharashtra and Gujarat.
Simplify reports with AI and introduce specialised testing packages.